亚太-话题@MedSci - williamhill asia

#亚太#

79篇内容 | 1440人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687594, encodeId=e967168e594ea, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=有心脏病，就应查睡眠呼吸暂停！亚太共识, objectType=article, longId=732053, objectId=e59de32053ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e59de32053ea, replyNumber=0, likeNumber=53, createdTime=2023-05-02, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e59de32053ea, moduleTitle=有心脏病，就应查睡眠呼吸暂停！亚太共识, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e59de32053ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687593, encodeId=2c27168e59384, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=亚太最新临床研究结果发布，糖尿病创新药物iGlarLixi降糖效果和安全性更优！, objectType=article, longId=724737, objectId=412de247372e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=412de247372e, replyNumber=0, likeNumber=64, createdTime=2022-11-10, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=412de247372e, moduleTitle=亚太最新临床研究结果发布，糖尿病创新药物iGlarLixi降糖效果和安全性更优！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=412de247372e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687591, encodeId=2e51168e5914f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=《2021年亚太肝病学会临床实践威廉亚洲博彩公司 :与免疫抑制治疗相关的HBV再激活》摘译, objectType=article, longId=295205, objectId=5de729520580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5de729520580, replyNumber=0, likeNumber=58, createdTime=2022-11-29, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5de729520580, moduleTitle=《2021年亚太肝病学会临床实践威廉亚洲博彩公司 :与免疫抑制治疗相关的HBV再激活》摘译, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5de729520580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687590, encodeId=ab1e168e590cf, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=威廉亚洲博彩公司解读丨亚太红斑狼疮威廉亚洲博彩公司，这26条重点都划好了！, objectType=article, longId=218802, objectId=338b2188026f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=338b2188026f, replyNumber=0, likeNumber=114, createdTime=2022-03-28, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=338b2188026f, moduleTitle=威廉亚洲博彩公司解读丨亚太红斑狼疮威廉亚洲博彩公司，这26条重点都划好了！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=338b2188026f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687592, encodeId=095e168e5927d, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛, objectType=article, longId=295705, objectId=74b3295e05cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b3295e05cf, replyNumber=0, likeNumber=53, createdTime=2022-12-29, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b3295e05cf, moduleTitle=亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=74b3295e05cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687589, encodeId=6942168e589f4, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=高德美亚太GAIN网络医生研讨会, objectType=article, longId=215358, objectId=b5b9215358d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5b9215358d4, replyNumber=0, likeNumber=63, createdTime=2022-02-10, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5b9215358d4, moduleTitle=高德美亚太GAIN网络医生研讨会, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=b5b9215358d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687587, encodeId=56ab168e5870b, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=JNNP：诺西那生钠治疗新生儿至青年1型脊髓性肌萎缩症：来自三个亚太地区的1年数据, objectType=article, longId=208468, objectId=f58c2084687a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f58c2084687a, replyNumber=0, likeNumber=99, createdTime=2021-07-03, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f58c2084687a, moduleTitle=JNNP：诺西那生钠治疗新生儿至青年1型脊髓性肌萎缩症：来自三个亚太地区的1年数据, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f58c2084687a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687586, encodeId=e2ed168e586f7, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=JNNP:诺西那生钠治疗1型脊髓性肌萎缩症的的新生儿至青年数据——来自三个亚太地区的1年数据, objectType=article, longId=207366, objectId=081e20e36698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081e20e36698, replyNumber=0, likeNumber=67, createdTime=2021-09-10, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081e20e36698, moduleTitle=JNNP:诺西那生钠治疗1型脊髓性肌萎缩症的的新生儿至青年数据——来自三个亚太地区的1年数据, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=081e20e36698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687588, encodeId=de89168e58845, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码, objectType=article, longId=189159, objectId=72291891594c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72291891594c, replyNumber=0, likeNumber=59, createdTime=2020-11-22, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72291891594c, moduleTitle=精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=72291891594c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687582, encodeId=5027168e5826f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=2019 共识声明：骨转换标志物用于亚太地区骨质疏松症治疗短期监测, objectType=article, longId=166266, objectId=19ae16626620, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ae16626620, replyNumber=0, likeNumber=41, createdTime=2020-03-11, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ae16626620, moduleTitle=2019 共识声明：骨转换标志物用于亚太地区骨质疏松症治疗短期监测, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=19ae16626620)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687583, encodeId=a1aa168e583bb, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=陆舜教授：促进亚太地区肺癌诊疗水平的提高，中国专家任重而道远, objectType=article, longId=172229, objectId=69241e2229c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69241e2229c3, replyNumber=0, likeNumber=58, createdTime=2019-07-27, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69241e2229c3, moduleTitle=陆舜教授：促进亚太地区肺癌诊疗水平的提高，中国专家任重而道远, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=69241e2229c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687580, encodeId=7ea6168e580f4, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”, objectType=article, longId=161350, objectId=2713161350cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2713161350cb, replyNumber=0, likeNumber=57, createdTime=2019-05-06, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2713161350cb, moduleTitle=信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2713161350cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687581, encodeId=c300168e5819c, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=Chin Med J (Engl)：亚太地区哮喘和过敏性鼻炎医生调查, objectType=article, longId=164401, objectId=116316440142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=116316440142, replyNumber=0, likeNumber=59, createdTime=2019-08-15, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=116316440142, moduleTitle=Chin Med J (Engl)：亚太地区哮喘和过敏性鼻炎医生调查, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=116316440142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687585, encodeId=f641168e5852e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=Gut：亚太胃肠病学会和亚太消化内镜学会粪便微生物移植共识, objectType=article, longId=181284, objectId=2e3b18128439, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3b18128439, replyNumber=0, likeNumber=61, createdTime=2020-04-12, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3b18128439, moduleTitle=Gut：亚太胃肠病学会和亚太消化内镜学会粪便微生物移植共识, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2e3b18128439)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687584, encodeId=29eb168e58455, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务, objectType=article, longId=176052, objectId=89f11e605222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f11e605222, replyNumber=0, likeNumber=49, createdTime=2019-07-29, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f11e605222, moduleTitle=精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=89f11e605222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687577, encodeId=133f168e577ea, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=第十届亚太地区循证医学研讨会召开，推动循证中医药学发展, objectType=article, longId=151904, objectId=0656151904ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0656151904ae, replyNumber=0, likeNumber=71, createdTime=2019-05-23, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0656151904ae, moduleTitle=第十届亚太地区循证医学研讨会召开，推动循证中医药学发展, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=0656151904ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687578, encodeId=2472168e578e0, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=上海张江：将打造亚太地区一流癌症治疗中心, objectType=article, longId=155371, objectId=33d51553e197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d51553e197, replyNumber=0, likeNumber=65, createdTime=2019-04-25, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d51553e197, moduleTitle=上海张江：将打造亚太地区一流癌症治疗中心, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=33d51553e197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687579, encodeId=ce92168e579e8, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=BookDoc携手亚太区特奥会鼓励智障人士拥有积极的生活方式, objectType=article, longId=158590, objectId=7f5615859059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f5615859059, replyNumber=0, likeNumber=50, createdTime=2019-03-13, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f5615859059, moduleTitle=BookDoc携手亚太区特奥会鼓励智障人士拥有积极的生活方式, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7f5615859059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687576, encodeId=3c84168e576df, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=2018罗氏诊断亚太心脏标志物研讨会全新热点追踪：解码心脏生物标志物守护健康“心”未来, objectType=article, longId=151826, objectId=ae8215182698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae8215182698, replyNumber=0, likeNumber=75, createdTime=2019-03-28, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae8215182698, moduleTitle=2018罗氏诊断亚太心脏标志物研讨会全新热点追踪：解码心脏生物标志物守护健康“心”未来, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ae8215182698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687574, encodeId=4b83168e5748f, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, objectTitle=Int Arch Allergy Immunol：亚太地区慢性呼吸道疾病的医疗模式研究, objectType=article, longId=140925, objectId=7511140925c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7511140925c2, replyNumber=0, likeNumber=58, createdTime=2018-12-05, rootId=0, userName=ms2536978994064944, userId=6ef428388125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7511140925c2, moduleTitle=Int Arch Allergy Immunol：亚太地区慢性呼吸道疾病的医疗模式研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7511140925c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

亚太

2020-05-29

智智灵药 (审核中...)

前往app查看评论内容

#亚太#

有心脏病，就应查睡眠呼吸暂停！亚太共识

2023-05-02

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

亚太最新临床研究结果发布，糖尿病创新药物iGlarLixi降糖效果和安全性更优！

2022-11-10

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

《2021年亚太肝病学会临床实践威廉亚洲博彩公司 :与免疫抑制治疗相关的HBV再激活》摘译

2022-11-29

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

威廉亚洲博彩公司解读丨亚太红斑狼疮威廉亚洲博彩公司，这26条重点都划好了！

2022-03-28

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛

2022-12-29

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

高德美亚太GAIN网络医生研讨会

2022-02-10

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

JNNP：诺西那生钠治疗新生儿至青年1型脊髓性肌萎缩症：来自三个亚太地区的1年数据

2021-07-03

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

JNNP:诺西那生钠治疗1型脊髓性肌萎缩症的的新生儿至青年数据——来自三个亚太地区的1年数据

2021-09-10

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码

2020-11-22

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

2019 共识声明：骨转换标志物用于亚太地区骨质疏松症治疗短期监测

2020-03-11

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

陆舜教授：促进亚太地区肺癌诊疗水平的提高，中国专家任重而道远

2019-07-27

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”

2019-05-06

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

Chin Med J (Engl)：亚太地区哮喘和过敏性鼻炎医生调查

2019-08-15

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

Gut：亚太胃肠病学会和亚太消化内镜学会粪便微生物移植共识

2020-04-12

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务

2019-07-29

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

第十届亚太地区循证医学研讨会召开，推动循证中医药学发展

2019-05-23

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

上海张江：将打造亚太地区一流癌症治疗中心

2019-04-25

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

BookDoc携手亚太区特奥会鼓励智障人士拥有积极的生活方式

2019-03-13

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

2018罗氏诊断亚太心脏标志物研讨会全新热点追踪：解码心脏生物标志物守护健康“心”未来

2019-03-28

ms2536978994064944 (审核中...)

前往app查看评论内容

#亚太#

Int Arch Allergy Immunol：亚太地区慢性呼吸道疾病的医疗模式研究

2018-12-05

科室
- - 订阅+
  - 更多科室
工具
服务